Representation in Clinical Trials

Research institutions have long struggled with accurate population representation in clinical trials. The growing proliferation of digital in healthcare ecosystems makes this more likely, but it is not perfect. UCLA Health’s Dr. Arash Naeim and Dr. Medell Briggs-Malonson share their efforts to progress the intersectionality of health technology and health audience in clinical trials and beyond. Verizon’s Robin Goldsmith and Ned Chini round out this conversation with the role devices and connectivity play in achieving representation.

Recent Episodes

In this special episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims, Chief Marketing Officer and Host at CGFNS International, dives deep into the critical role of English language proficiency in global healthcare workforce mobility. Joined by guest Spiros Papageorgiou, Principal Measurement Scientist at ETS, the discussion unpacks how language proficiency benchmarks…

The rising cost of healthcare continues to strain employers and employees alike. With premiums climbing at a rate outpacing inflation, many organizations are burdened with high costs and subpar outcomes. Employer-built healthcare models are emerging as a potential solution, enabling organizations to take control of their healthcare systems. According to the Kaiser Family Foundation,…

Women’s health remains a critical issue globally, with alarming disparities in access and outcomes. A new survey from Hologic and Gallup reveals that while nearly 90% of women recognize the importance of health screenings, less than half undergo them consistently due to barriers like cost, time, and anxiety. The stakes are particularly high in…